BioTech Breakthrough Awards
Recognizing the world’s best Life Sciences & BioTechnology companies, products and services
We are passionate about what technology can do for the world and we are committed to providing a platform for recognition dedicated to standout biotechnology companies, services and products throughout the world.
With acquisitions, partnerships, IPOs, and fundraising still increasing, biotech’s prominence has risen higher than it was before the COVID pandemic. The industry’s response to the crisis, its record of innovation, and its reputation continue to grow.
With the growth in the number of BioTechnology companies in the industry, how can you stand out in a crowded market? How do you break out from the industry noise? Nominate for a BioTech Breakthrough Award today and BREAK THROUGH!
Advances in biological sciences, combined with the accelerating development of computing, data processing, and artificial intelligence, are fueling a new wave of innovation that could have significant impact in sectors across the economy, from healthcare and agriculture to consumer goods and energy.
These new capabilities and applications are already improving our response to global challenges from climate change to pandemics and beyond.
A flurry of recent innovations such as CRISPR to edit genes and stem cell advances to reprogram cells—are providing new understanding, new materials, new tools, as well as lower costs. With the growing number of innovative biotechnology solutions and services on the marketplace, how can you stand out in a crowded market?
As advances in biological science and their practical application transform our economy and society, we aim to highlight the BREAKTHROUGH biotechnology solutions, services and companies around the world each year. The BioTech Breakthrough Awards program aims to perform the most comprehensive evaluation of life sciences and biotechnology tools, services and companies today, with nominations coming in from the best and brightest biotechnology innovators around the world.
The reduced cost of genetic sequencing allow for much more extensive screening of trial participants and targeting of interventions. This has enabled the development of personalized treatment plans and targeted therapies, which are more effective than less-specific therapies.
Meats produced without animals
Synthetic silks produced by microbe factories
Monogenic diseases prevented at birth
Personalized diets based on your genome
Percentage of the world’s physical inputs that could potentially be made using biological means
Percentage of the world’s disease burden that could be addressed
Percentage of private-sector R&D spent in biology-related industries
The mission of the annual BioTech Breakthrough Awards program is to honor excellence and recognize the creativity, hard work and success of companies, technologies and products within the field of biotechnology.
BioTech Breakthrough winners receive well-deserved industry recognition and third-party validation from an independent organization. The program is open to all individuals, companies and organizations involved in producing publicly available products and services. To be eligible, an entry must have been produced or updated after August 1, 2021 (2-year window).
Earning the coveted BioTech Breakthrough Award provides compelling benefits.
Submission Period: July 17 – September 15, 2023
Complete and submit for your entry online by September 15, 2023. Emailed or hard copy submission forms will not be accepted.
Mapping and engineering intracellular molecules
Mapping and engineering cells, tissues, and organs
Connecting nervous systems of living organisms to machines
Using cells and cellular components for computation
BioTech Breakthrough Awards recognizes that many of the entries are internal or proprietary in nature, or are done for the government or another company, so unless you grant permission for your entries to be displayed in our winner’s gallery, only the judges will see your work.
Entries will not be returned unless special arrangements are made. No entrant information is sold, traded, made available to a third party or used for any other purpose.